EC Plans Directive on GMPs for Excipients
ePT--the Electronic Newsletter of Pharmaceutical Technology
Brussels, Belgium (Mar. 22)-The European Commission?s (EC) Directorate-General for Enterprise and Industry (Brussels, Belgium) is asking manufacturers, distributors, and users of human-pharmaceutical excipients to participate in an online questionnaire on the effect of various policy options. Responses will be used to prepare a directive on good manufacturing practices (GMPs) for certain excipients.
Brussels, Belgium (Mar. 22)-The European Commission’s (EC) Directorate-General for Enterprise and Industry (Brussels, Belgium, http://ec.europa.eu/index_en.htm) is asking manufacturers, distributors, and users of human-pharmaceutical excipients to participate in an online questionnaire on the effect of various policy options. Responses will be used to prepare a directive on good manufacturing practices (GMPs) for certain excipients.
DG Enterprise and Industry will share the results of the questionnaire with Europe Economics (London, UK, www.europe-economics.com), an external contractor, for analysis. The results will then be written in a report, with parts made available to the public. The report will not reveal information that will allow retrieval of company-specific data.
A draft entitled “Specific Conditions of the Application of the Principles and Guidelines of GMP for Certain Excipients” is planned for publication as a possible basis for the GMP directive.
The questionnaire should be completed by July 30, 2007 and can be accessed by visiting http://ec.europa.eu/enterprise/pharmaceuticals/index_en.htm
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
